DY
Dyadic International, Inc.
DYAI · NASDAQ
$0.52 -2.77% (-$0.01)
1M -47.74%
Market Cap $19.0M
P/E Ratio -
Div. Yield -
ROE 2,918.10%
Piotroski F-Score Weak
3/9Valuation
30 /100
Expensive P/S 5.46x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 25.08%
Book val. growth 51.92%
EPS growth N/A
Profitability
11 /100
Weak Gross margin 30.44%
Net margin 219.50%
Op. margin 213.59%
Quality
7 /100
Poor ROIC 278.95%
ROE 2,918.10%
ROA 116.60%
Debt
36 /100
Moderate Current ratio 1.65x
Int. coverage -17.20x
Debt/Equity N/A
Stability
42 /100
Moderate Beta 1.15x
Rev. volatility 44.35%
EPS volatility 22.87%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DYAI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Mark A. Emalfarb
Employees
5
Headquarters
Jupiter
Upcoming events
11 NOV
Earnings
Upcoming earnings report